215 related articles for article (PubMed ID: 20651942)
1. c-myc and N-myc promote active stem cell metabolism and cycling as architects of the developing brain.
Wey A; Knoepfler PS
Oncotarget; 2010 Jun; 1(2):120-30. PubMed ID: 20651942
[TBL] [Abstract][Full Text] [Related]
2. c- and N-myc regulate neural precursor cell fate, cell cycle, and metabolism to direct cerebellar development.
Wey A; Martinez Cerdeno V; Pleasure D; Knoepfler PS
Cerebellum; 2010 Dec; 9(4):537-47. PubMed ID: 20658325
[TBL] [Abstract][Full Text] [Related]
3. Dissection of the MYCN locus in Feingold syndrome and isolated oesophageal atresia.
Cognet M; Nougayrede A; Malan V; Callier P; Cretolle C; Faivre L; Genevieve D; Goldenberg A; Heron D; Mercier S; Philip N; Sigaudy S; Verloes A; Sarnacki S; Munnich A; Vekemans M; Lyonnet S; Etchevers H; Amiel J; de Pontual L
Eur J Hum Genet; 2011 May; 19(5):602-6. PubMed ID: 21224895
[TBL] [Abstract][Full Text] [Related]
4. N-Myc regulates expression of pluripotency genes in neuroblastoma including lif, klf2, klf4, and lin28b.
Cotterman R; Knoepfler PS
PLoS One; 2009 Jun; 4(6):e5799. PubMed ID: 19495417
[TBL] [Abstract][Full Text] [Related]
5. N-Myc and GCN5 regulate significantly overlapping transcriptional programs in neural stem cells.
Martínez-Cerdeño V; Lemen JM; Chan V; Wey A; Lin W; Dent SR; Knoepfler PS
PLoS One; 2012; 7(6):e39456. PubMed ID: 22745758
[TBL] [Abstract][Full Text] [Related]
6. Germline deletion of the miR-17∼92 cluster causes skeletal and growth defects in humans.
de Pontual L; Yao E; Callier P; Faivre L; Drouin V; Cariou S; Van Haeringen A; Geneviève D; Goldenberg A; Oufadem M; Manouvrier S; Munnich A; Vidigal JA; Vekemans M; Lyonnet S; Henrion-Caude A; Ventura A; Amiel J
Nat Genet; 2011 Sep; 43(10):1026-30. PubMed ID: 21892160
[TBL] [Abstract][Full Text] [Related]
7. GENETIC COUNSELLING IN FEINGOLD SYNDROME AND A NOVEL MUTATION.
Atik T; Güvenç MS; Onay H; Özkinay F; Çoğulu Ö
Genet Couns; 2016; 27(3):381-384. PubMed ID: 30204967
[TBL] [Abstract][Full Text] [Related]
8. Gain-of-function MYCN causes a megalencephaly-polydactyly syndrome manifesting mirror phenotypes of Feingold syndrome.
Nishio Y; Kato K; Tran Mau-Them F; Futagawa H; Quélin C; Masuda S; Vitobello A; Otsuji S; Shawki HH; Oishi H; Thauvin-Robinet C; Takenouchi T; Kosaki K; Takahashi Y; Saitoh S
HGG Adv; 2023 Oct; 4(4):100238. PubMed ID: 37710961
[TBL] [Abstract][Full Text] [Related]
9. Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models.
Mirzamohammadi F; Kozlova A; Papaioannou G; Paltrinieri E; Ayturk UM; Kobayashi T
Nat Commun; 2018 Apr; 9(1):1352. PubMed ID: 29636449
[TBL] [Abstract][Full Text] [Related]
10. A Novel MYCN Variant Associated with Intellectual Disability Regulates Neuronal Development.
Yu X; Hu L; Liu X; Zhan G; Mei M; Wang H; Zhang X; Qiu Z; Zhou W; Yang L
Neurosci Bull; 2018 Oct; 34(5):854-858. PubMed ID: 29786759
[No Abstract] [Full Text] [Related]
11. SIRT1 regulates sphingolipid metabolism and neural differentiation of mouse embryonic stem cells through c-Myc-SMPDL3B.
Fan W; Tang S; Fan X; Fang Y; Xu X; Li L; Xu J; Li JL; Wang Z; Li X
Elife; 2021 May; 10():. PubMed ID: 34042046
[TBL] [Abstract][Full Text] [Related]
12. The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain.
Zhao X; D' Arca D; Lim WK; Brahmachary M; Carro MS; Ludwig T; Cardo CC; Guillemot F; Aldape K; Califano A; Iavarone A; Lasorella A
Dev Cell; 2009 Aug; 17(2):210-21. PubMed ID: 19686682
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular characterizations of 11 new patients with type 1 Feingold syndrome: Proposal for selecting diagnostic criteria and further genetic testing in patients with severe phenotype.
Tedesco MG; Lonardo F; Ceccarini C; Cesarano C; Digilio MC; Magliozzi M; Rogaia D; Mencarelli A; Leoni C; Piscopo C; Imperatore V; Falco MT; Fontana P; Nardone AM; Novelli A; Troiani S; Seri M; Prontera P
Am J Med Genet A; 2021 Apr; 185(4):1204-1210. PubMed ID: 33442900
[TBL] [Abstract][Full Text] [Related]
14. [Association esophageal atresia type 3 - microcephaly: an incomplete Feingold syndrome?].
Shongo MY; Lubala TK; Mbuyi SM; Makinko PI; Ngwej DT; Kabange FN
Pan Afr Med J; 2012; 13():85. PubMed ID: 23396887
[TBL] [Abstract][Full Text] [Related]
15. Neurobehavioral Alterations in a Genetic Murine Model of Feingold Syndrome 2.
Fiori E; Babicola L; Andolina D; Coassin A; Pascucci T; Patella L; Han YC; Ventura A; Ventura R
Behav Genet; 2015 Sep; 45(5):547-59. PubMed ID: 26026879
[TBL] [Abstract][Full Text] [Related]
16. A novel mutation in MYCN gene causing congenital absence of the flexor pollicis longus tendon as an unusual presentation of Feingold syndrome 1.
Peleg A; Kurolap A; Sagi-Dain L; Larom-Khan G; Adir V; Mory A; Paperna T; Shuldiner AR; Gonzaga-Jauregui C; Adir N; Baris Feldman H; Wollstein R
Clin Dysmorphol; 2021 Apr; 30(2):71-75. PubMed ID: 32925198
[TBL] [Abstract][Full Text] [Related]
17. myc maintains embryonic stem cell pluripotency and self-renewal.
Varlakhanova NV; Cotterman RF; deVries WN; Morgan J; Donahue LR; Murray S; Knowles BB; Knoepfler PS
Differentiation; 2010 Jul; 80(1):9-19. PubMed ID: 20537458
[TBL] [Abstract][Full Text] [Related]
18. Nestin is a potential mediator of malignancy in human neuroblastoma cells.
Thomas SK; Messam CA; Spengler BA; Biedler JL; Ross RA
J Biol Chem; 2004 Jul; 279(27):27994-9. PubMed ID: 15117961
[TBL] [Abstract][Full Text] [Related]
19. Features of Feingold syndrome 1 dominate in subjects with 2p deletions including MYCN.
Burnside RD; Molinari S; Botti C; Brooks SS; Chung WK; Mehta L; Schwartz S; Papenhausen P
Am J Med Genet A; 2018 Sep; 176(9):1956-1963. PubMed ID: 30088856
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing.
Aravalli RN; Talbot NC; Steer CJ
World J Gastroenterol; 2015 Feb; 21(7):2011-29. PubMed ID: 25717234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
